FDA Clearance Tracker · P030022
REFLECTION CERAMIC ACETABULAR SYSTEM
Last checked: Nov 20, 2026Latest source record: Dec 17, 2004 (this decision)Source: openFDAMethods & limitations
Decided
Dec 17, 2004
Approval withdrawn
Time to decision
555 days
Received Jun 11, 2003. Calendar days, including time FDA spent waiting on the applicant.
Pathway
PMA
Device class
Class III
The decision
- FDA number
- P030022
- Device name
- REFLECTION CERAMIC ACETABULAR SYSTEM
- Applicant
- Smith & Nephew, Inc.
- Applicant location
- Memphis, TN
- Received
- Jun 11, 2003
- Decided
- Dec 17, 2004
- Decision
- Approval withdrawn
- Supplements
- 47 in FDA's data for this PMA. See them on the FDA record
Device type
- Device type
- Prosthesis, hip, semi-constrained, metal/ceramic/ceramic/metal, cemented or uncemented (MRA)
- Device class
- Class III
FDA's approval statement
As written in FDA's record.
APPROVAL FOR THE REFLECTION CERAMIC ACETABULAR SYSTEM. THE DEVICE IS INDICATED FOR USE IN PATIENTS REQUIRING PRIMARY TOTAL HIP ARTHROPLASTY DUE TO NON-INFLAMMATORY ARTHRITIS (DEGENERATIVE JOINT DISEASE) SUCH AS OSTEOARTHRITIS, AVASCULAR NECROSIS, OR TRAUMATIC ARTHRITIS.
How new is this?
These are facts about FDA's records. They are not a judgment about the device.
- It is not the first decision under product code MRA. The earliest in FDA's data is P810048, decided Nov 5, 1982.
- It is not on FDA's public list of Breakthrough Devices with marketing authorization (list dated June 30, 2026). FDA does not publish which devices hold the designation before they are authorized, and the list is updated only a few times a year.
Source documents
Other decisions for Smith & Nephew, Inc.
Matched on the applicant name as FDA recorded it. A company that files under several names will have more.
- Tendon Anchor510(k)
K263461 · Decided Oct 27, 2026 · 29 days after receipt
Device type: Staple, Implantable (GDW) · General & Plastic Surgery
7 more FDA decisions with a free account
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.